Showing results (51-60 of 103) with videos related to
Sort By:
Pageof 11
The Journal of Clinical Investigation|October 8, 2005
The role of 2 FOXP3 isoforms in the generation of human CD4+ TregsSarah E Allan, Laura Passerini, Rosa Bacchetta, et al.Haematologica|July 18, 2009
Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemiaGiorgia Serafini, Marco Andreani, Manuela Testi, et al.The Journal of Experimental Medicine|April 20, 2005
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cellsSilvia Gregori, Patrizia Mangia, Rosa Bacchetta, et al.Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|October 11, 2008
Clinical improvement and normalized Th1 cytokine profile in early and long-term interferon-alpha treatment in a suspected case of hyper-IgE syndromeUlrike Benninghoff, Federica Cattaneo, Alessandro Aiuti, et al.Clinical & Translational Immunology|December 11, 2020
Human-engineered Treg-like cells suppress FOXP3-deficient T cells but preserve adaptive immune responses <i>in vivo</i>Yohei Sato, Laura Passerini, Brian D Piening, et al.The Journal of Allergy and Clinical Immunology|July 11, 2017
Peanut-specific type 1 regulatory T cells induced in vitro from allergic subjects are functionally impairedLaurence Pellerin, Jennifer Anne Jenks, Sharon Chinthrajah, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|November 7, 2007
Generation of potent and stable human CD4+ T regulatory cells by activation-independent expression of FOXP3Sarah E Allan, Alicia N Alstad, Natacha Merindol, et al.The Journal of Allergy and Clinical Immunology|April 30, 2018
Role of human forkhead box P3 in early thymic maturation and peripheral T-cell homeostasisFrancesca R Santoni de Sio, Laura Passerini, Silvia Restelli, et al.Haematologica|August 18, 2010
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapyRosa Bacchetta, Silvia Gregori, Giorgia Serafini, et al.Cytotherapy|August 18, 2021
Pre-clinical development and molecular characterization of an engineered type 1 regulatory T-cell product suitable for immunotherapyJeffrey Mao-Hwa Liu, Ping Chen, Molly Javier Uyeda, et al.Pageof 11